SBC Medical Group Holdings Incorporated cash flow to debt ratio of 75.38% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

SBC Medical Group Holdings Incorporated's free cash flow has increased 112.82% from $17.17M last year to $36.55M, signaling increasing performance

SBC Medical Group Holdings Incorporated's debt to equity ratio is 0.20, which means that the company's assets are healthy financed, signaling financial stability.

SBC Medical Group Holdings Incorporated's debt has increased relative to shareholder equity from 0.06 last year to 0.20 today, signaling weakened financials

SBC Medical Group Holdings Incorporated has a net cash position, so leverage is healthy.

SBC Medical Group Holdings Incorporated earns at least as much interest as it pays. Interest obligations are fully covered.

SBC Medical Group Holdings Incorporated's profit margin has increased (6.15%) in the last year from 22.69% to 24.09%, signaling increasing performance

SBC Medical Group Holdings Incorporated's short-term assets of $231.22M exceed its short-term liabilities of $61.12M

SBC Medical Group Holdings Incorporated's return on assets of 10.51% is higher than the 5.00% threshold, indicating efficient asset utilization

SBC Medical Group Holdings Incorporated's return on equity of 16.38%, is higher than 15.00%, indicating good performance

SBC Medical Group Holdings Incorporated's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

SBC Medical Group Holdings Incorporated has insufficient public price history to evaluate earnings stability.

SBC Medical Group Holdings Incorporated has positive free cash flow, indicating the company generates cash after capital expenditures

SBC Medical Group Holdings Incorporated has a free cash flow yield of 11.54%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

SBC Medical Group Holdings Incorporated's yearly earnings has increased 9.38% since last year from $46.61M to $50.99M, signaling increasing performance

SBC Medical Group Holdings Incorporated's yearly revenue has decreased 15.48% since last year from $205.42M to $173.61M, signaling decreasing performance

ROIC 10.56% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

SBC Medical Group Holdings Incorporated's 3-year revenue CAGR of -0.11% is negative, indicating declining revenue over the past 3 years

SBC Medical Group Holdings Incorporated has insufficient public price history to evaluate revenue consistency.

SBC Medical Group Holdings Incorporated has insufficient public price history to evaluate ROE consistency.

SBC Medical Group Holdings Incorporated has insufficient data to evaluate this check.

SBC Medical Group Holdings Incorporated has an earnings yield of 12.91%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

SBC Medical Group Holdings Incorporated is undervalued relative to its fair value price of 5.89 based on EBITDA multiple model

SBC Medical Group Holdings Incorporated has an EV/EBITDA ratio of 2.41x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

SBC Medical Group Holdings Incorporated has insufficient data to evaluate this check.

SBC Medical Group Holdings Incorporated has insufficient diluted EPS history to calculate the PEG ratio.

SBC Medical Group Holdings Incorporated has a price-to-book ratio of 1.17x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

SBC Medical Group Holdings Incorporated has a price-to-sales ratio of 1.87x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue